Correlation of a T45S variant of apolipoprotein C1 with elevated BMI in persons of American Indian and Mexican ancestries

International Journal of Obesity

Volumn 31, Issue 8, 2007, Pages 1334-1336

  Kasthuri, R S ^a   McMillan, K R ^b   Flood Urdangarin, C ^c   Harvey, S B ^d   Wilson Grady, J T ^d   Nelsestuen, G L ^d,e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b American Indian Community Development Corporation   (United States)

^c St Mary's Health Clinics   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e NONE   (United States)

Author keywords

American Indian; Apoliprotein C1; Mexican American

Indexed keywords

APOLIPOPROTEIN C1; NUCLEIC ACID;

ADULT; AMERICAN INDIAN; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; GENETIC CORRELATION; GENETIC VARIABILITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIBLING;

ADULT; APOLIPOPROTEIN C-I; BODY MASS INDEX; DIABETES MELLITUS; DNA; FEMALE; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; OBESITY; PREVALENCE; SEQUENCE ANALYSIS, DNA; UNITED STATES; VARIATION (GENETICS);

EID: 34547441397     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803569     Document Type: Article

References (15)

1. Conde-Knape K, Bensadoun A, Sobel JH, Cohn JS, Shachter NS. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase. J Lipid Res (2002); 43: 2136-2145.
2. Berbee JF, van der Hoogt CC, Sundararaman D, Havekes LM, Rensen PC. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J Lipid Res (2005); 46: 297-306.
3. Poensgen J. Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes. Biochim Biophys Acta (1990); 1042: 188-192.
4. Gautier T, Masson D, de Barros JP, Athias A, Gambert P, Aunis D et al. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J Biol Chem (2000); 275: 37504-37509.
5. Kushwaha RS, Hasan SQ, McGill Jr HC, Getz GS, Dunham RG, Kanda P. Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons (Papio sp.). J Lipid Res (1993); 34: 1285-1297.
6. Weisgraber KH, Mahley RW, Kowal RC, Herz J, Goldstein JL, Brown MS. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem (1990); 265: 22453-22459.
7. Liu M, Subbaiah PV. Activation of plasma lysolecithin acyltransferase reaction by apolipoproteins A-I, C-I and E. Biochim Biophys Acta (1993); 1168: 144-152.
8. Cohn JS, Tremblay M, Boulet L, Jacques H, Davignon J, Roy M et al. Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism. Atherosclerosis (2003); 169: 63-70.
9. Shachter NS, Rabinowitz D, Stohl S, Conde-Knape K, Cohn JS, Deckelbaum RJ et al. The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children. Atherosclerosis (2005); 179: 387-393.
10. Gao L, Gabriel C, Lavoie T, Ye SQ. An improved RSP method to detect HpaI polymorphism in the apolipoprotein C-1 gene promoter. BMC Med Genet (2002); 3: 13.
11. Shi J, Zhang S, Ma C, Liu X, Li T, Tang M et al. Association between apolipoprotein CI HpaI polymorphism and sporadic Alzheimer's disease in Chinese. Acta Neurol Scand (2004); 109: 140-145.
12. Retz W, Thome J, Durany N, Harsanyi A, Retz-Junginger P, Kornhuber J et al. Potential genetic markers of sporadic Alzheimer's dementia. Psychiatr Genet (2001); 11: 115-122.
13. Muurling M, van den Hoek AM, Mensink RP, Pijl H, Romijn JA, Havekes LM et al. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res (2004); 45: 9-16.
14. Wroblewski MS, Wilson-Grady JT, Martinez MB, Kasthuri RS, McMillan KR, Flood-Urdangarin C et al. A functional polymorphism of apolipoprotein C1 detected by mass spectrometry. FEBS J (2006); 273: 4107-4115.
15. Nelsestuen GL, Zhang Y, Martinez MB, Key NS, Jilma B, Verneris M et al. Plasma protein profiling: unique and stable features of the plasma proteome. Proteomics (2005); 5: 4012-4024.